Howard Hughes Medical Institute held its stake in shares of Morgan Stanley (NYSE:MS) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 100,000 shares of the financial services provider’s stock at the end of the second quarter. Howard Hughes Medical Institute’s holdings in Morgan Stanley were worth $4,456,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Stevens Capital Management LP acquired a new position in shares of Morgan Stanley in the 2nd quarter worth approximately $9,846,000. Investment Centers of America Inc. boosted its holdings in shares of Morgan Stanley by 69.0% in the 2nd quarter. Investment Centers of America Inc. now owns 14,391 shares of the financial services provider’s stock worth $639,000 after acquiring an additional 5,878 shares in the last quarter. BT Investment Management Ltd acquired a new position in shares of Morgan Stanley in the 2nd quarter worth approximately $1,239,000. BlueMountain Capital Management LLC boosted its holdings in shares of Morgan Stanley by 32.9% in the 2nd quarter. BlueMountain Capital Management LLC now owns 18,638 shares of the financial services provider’s stock worth $831,000 after acquiring an additional 4,615 shares in the last quarter. Finally, Amalgamated Bank boosted its holdings in shares of Morgan Stanley by 49.5% in the 2nd quarter. Amalgamated Bank now owns 150,347 shares of the financial services provider’s stock worth $6,699,000 after acquiring an additional 49,762 shares in the last quarter. 85.20% of the stock is currently owned by institutional investors and hedge funds.
MS has been the topic of several recent analyst reports. Vetr raised Morgan Stanley from a “sell” rating to a “hold” rating and set a $40.50 target price on the stock in a report on Tuesday, May 23rd. J P Morgan Chase & Co reissued a “buy” rating on shares of Morgan Stanley in a report on Tuesday, May 23rd. Zacks Investment Research downgraded Morgan Stanley from a “buy” rating to a “hold” rating in a report on Wednesday, May 24th. Instinet reissued a “buy” rating and issued a $50.00 target price (down from $51.00) on shares of Morgan Stanley in a report on Saturday, June 3rd. Finally, Royal Bank Of Canada reissued a “buy” rating and issued a $50.00 target price on shares of Morgan Stanley in a report on Tuesday, June 6th. One research analyst has rated the stock with a sell rating, eight have given a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $48.48.
Shares of Morgan Stanley (NYSE MS) traded up 0.39% during mid-day trading on Friday, hitting $46.60. 9,113,079 shares of the company’s stock traded hands. Morgan Stanley has a 52 week low of $30.62 and a 52 week high of $48.90. The firm has a 50-day moving average of $46.09 and a 200 day moving average of $44.54. The company has a market cap of $85.58 billion, a PE ratio of 13.35 and a beta of 1.63.
Morgan Stanley (NYSE:MS) last issued its quarterly earnings results on Wednesday, July 19th. The financial services provider reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.11. The company had revenue of $9.50 billion for the quarter, compared to analyst estimates of $9.05 billion. Morgan Stanley had a net margin of 16.77% and a return on equity of 9.83%. Morgan Stanley’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.75 earnings per share. Equities research analysts predict that Morgan Stanley will post $3.50 EPS for the current year.
Morgan Stanley declared that its Board of Directors has authorized a share repurchase program on Wednesday, June 28th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the financial services provider to buy up to 6.1% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.
WARNING: “Howard Hughes Medical Institute Holds Position in Morgan Stanley (MS)” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2017/09/16/howard-hughes-medical-institute-holds-position-in-morgan-stanley-ms.html.
In other news, CFO Jonathan Pruzan sold 25,767 shares of Morgan Stanley stock in a transaction on Thursday, July 20th. The shares were sold at an average price of $46.68, for a total transaction of $1,202,803.56. Following the transaction, the chief financial officer now owns 196,708 shares in the company, valued at $9,182,329.44. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman James P. Gorman sold 212,366 shares of Morgan Stanley stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $47.26, for a total transaction of $10,036,417.16. Following the transaction, the chairman now owns 1,602,609 shares in the company, valued at approximately $75,739,301.34. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.
Morgan Stanley Profile
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.